Figure 2.
Kaplan–Meier curves for the treatment and control groups for pooled population 1 (a) and the curves for fluoropyrimidine combined with oxaliplatin compared to fluoropyrimidine monotherapy in pooled population 2 (b).
Kaplan–Meier curves for the treatment and control groups for pooled population 1 (a) and the curves for fluoropyrimidine combined with oxaliplatin compared to fluoropyrimidine monotherapy in pooled population 2 (b).